摘要
目的探讨冠心病(CHD)病人血清高迁移率族蛋白B1(HMGB1)和超敏C反应蛋白(hs-CRP)的变化及其临床意义。方法采用ELISA法和散射速率比浊法,测定60例不同类型CHD病人血清HMGB1和hs-CRP浓度变化,并与20例健康体检者(对照组)进行比较。结果 CHD病人血清HMGB1和hs-CRP水平明显增高,与对照组比较差异有显著性(t′=8.02、8.43,P〈0.01)。急性心肌梗死(AMI)病人血清HMGB1和hs-CRP水平均显著高于不稳定型心绞痛(UAP)病人、稳定型心绞痛(SAP)病人和对照组(F=31.48、24.60,q=4.32~12.84,P〈0.01);UAP病人血清HMGB1和hs-CRP水平显著高于SAP病人和对照组(q=3.98~8.51,P〈0.01);SAP病人血清HMGB1和hs-CRP水平与对照组比较差异亦有显著性(q=3.63、2.90,P〈0.05)。CHD病人血清HMGB1和hs-CRP水平呈正相关(r=0.287,P〈0.05)。血清HMGB1和hs-CRP水平在AMI、UAP组AUCROC均大于0.90,对AMI诊断的灵敏度和特异度分别为0.90、0.95和0.85、0.95,对UAP诊断的灵敏度和特异度分别为0.95、0.85和0.90、0.90。结论血清HMGB1和hs-CRP浓度的变化对AMI和UAP具有明显的诊断价值和较高的诊断准确度,可以作为评价CHD危险程度的指标之一。
Objective To explore the changes of serum levels of high-mobility group box l protein(HMGB1) and hypersensitive C-reactive protein(hs-CRP) in patients with coronary heart disease(CHD) and to discuss the related clinical significance.Methods The serum levels of HMGB1 and hs-CRP were detected by enzyme-linked immunosorbent assay and scatter velocity turbidimetry,respectively,among 60 patients with different types of CHD.The data obtained were compared with 20 healthy controls. Results The serum HMGB1 and hs-CRP of the CHD patients were significantly higher than that of the controls(t′=8.02,8.43;P0.01).The serum HMGB1 and hs-CRP of patients with acute myocardial infarction(AMI) were obviously higher than that of the patients with unstable angina pectoris(UAP),or those with stable angina pectoris(SAP) or of the controls(F=31.48,24.60;q=4.32-12.84;P0.01).The serum HMGB1 and hs-CRP of UAP patients were much higher than that of those with SAP and of the controls(q=3.98-8.51,P0.01);while the difference of serum HMGB1 and hs-CRP between SAP patients and the controls was also statistically different(q=3.63,2.90;P0.05).There was a positive correlation between serum HMGB1 and hs-CRP in patients with CHD(r=0.287,P0.05).The areas under the ROC curve(AUCROC) were all greater than 0.90.The sensitivity and specificity of HMGB1 and hs-CRP were 0.90,0.95 and 0.85,0.95 in patients with AMI.The sensitivity and specificity of HMGB1 and hs-CRP were 0.95,0.85 and 0.90,0.90 in patients with UAP. Conclusion The changes in serum levels of HMGB1 and hs-CRP are of higher accuracy in the diagnosis of patients with AMI or UAP,which can be used as one of the criteria to evaluate the risk of CHD.
出处
《青岛大学医学院学报》
CAS
2011年第2期129-131,134,共4页
Acta Academiae Medicinae Qingdao Universitatis